🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Flo Doo, MD and Joseph Murray discuss the benefits and limitations of ChatGPT for helping clinicians with #diagnosis and #treatment. Fascinating stuff! #jhprecisionmed23

Thank you Stephen V Liu, MD! Here, the Mount Sinai Early Phase Trials Unit (EPTU) shows that it is feasible to enroll a truly diverse patient population on phase 1 trials. #clinicaltrials The Tisch Cancer Institute 1/4

Keanu and liquid biopsies who would have thought? Elsa Anagnostou Joseph Murray

Great to see our latest collaborative #liquidbiopsy work published in Clinical Cancer Research ! #OpenAccess article here: aacrjournals.org/clincancerres/… Johns Hopkins Kimmel Cancer Center Johns Hopkins Thoracic Oncology Molecular OncologyLab AHN The Netherlands Cancer Institute Sibley Hospital JHM AACR

Phenomenal group of future ACSs, especially Barker’s own Christina Tamargo, Armani Hawes, and Jona Mata, MD. Thrilled for the next generation of Osler housestaff to learn from these incredible physicians, leaders, and people. Kudos to Natasha Chida, MD MSPH for assembling such a stellar team 💪🏻

Today we report in Cancer Research Communications the impact of ALK variants and co-mutations on acquired resistance patterns and survival in a clinical cohort of 309 pts mostly tx’ed with 1L alec/brig and a liquid biopsy cohort of 1118 ALK+ NSCLC pts. bit.ly/42SaYwE ALK Positive #LCSM 🧵

Here's our latest from Johns Hopkins Thoracic Oncology & Molecular OncologyLab, hot-off-the-press in Nature Medicine. What do we learn from neoadjuvant anti-PD1 & anti-LAG3 through the lens of liquid biopsies? Enjoy the read! nature.com/articles/s4159… Vincent Lam Cancer Research Institute Blair Landon

Out in Nature Medicine our phase Ib study of neoadjuvant nivo/nivo+LAG-3 + chemoRT in esoph/GEJ cancer; linking ctDNA w path/immune responses and RFS. nature.com/articles/s4159… Elsa Anagnostou Johns Hopkins Thoracic Oncology Conquer Cancer, the ASCO Foundation #esophagealcancer 1/5

The Molecular OncologyLab is on the way to #AACR24! Hope to see everyone at our presentations & poster sessions covering #liquidbiopsies #cancergenomics, #Immunotherapy #PrecisionOncology! + celebrating 3⃣ scholar-in-training awards! AACR Blair Landon Lavanya Sivapalan Maria Fatteh

Checkout our new Molecular OncologyLab website! anagnostoulab.org We are looking for new wet lab members to join our multi-omics and liquid biopsy efforts (research tech and post-doc level -the latter for folks with a PhD in cancer biology-), contact us if there is interest!

Amazing- human pancreas 80cm3…. That’s a lot of kras mutations - yet lifetime risk of pancreas cancer is 1:60 - cancer is very rare at the cellular level “mean burden of 13 PanINs per cm3; normal.. adult panc has 100s of PanINs, w oncogenic KRASm.” nature.com/articles/s4158…

Wonderful to see Lavanya Sivapalan featured in the C3PO Johns Hopkins Medicine post-doctoral series! Congrats for a phenomenal talk on dissecting immunotherapy response by liquid biopsies! Johns Hopkins Kimmel Cancer Center Johns Hopkins Postdoctoral Association (JHPDA)

Honored to be selected by ASH to participate in the ASH Minority Resident Hematology Award Program!!! #ASHAwards Hopkins Bayview IM Residency Johns Hopkins Kimmel Cancer Center Johns Hopkins Berman Institute of Bioethics

One degree hotter! 👨🏻‍🎓🩺 Thank you Kristen A. Marrone, MD for hooding me (and convincing me to stay in med school), and to all my other mentors I’m so lucky to have learned from Joseph Murray Katherine Chretien Rakhi Naik, MD MHS Lukasz Gondek JOSEPHINE FELICIANO Jarushka Naidoo Andi Shahu, MD MHS and so many more ❤️

Thrilled to share that my mentees @DanielShuMD and Mari Nakazawa are receiving ASCO Conquer Cancer, the ASCO Foundation Young Investigator Awards tomorrow. 🎉Nothing gives me more joy than seeing their hard work recognized. So proud of you both! conferences.asco.org/am/conquer-can…

Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in Nature Communications. nature.com/articles/s4146… 🧵

It’s almost July 1! Can’t wait to see this amazing new group of Osler interns grow and take fantastic care of patients under the leadership of their ACSs! #Oslerpride

Welcome to the KRAS Kickers and our patients to hear updates from our researchers! ⁦KRASKickers⁩ ⁦Johns Hopkins Thoracic Oncology⁩ ⁦Sandra Misale⁩ ⁦Kristen A. Marrone, MD⁩

Great work from the amazing Kaushal Parikh and nice summary from the venerable Jarushka Naidoo!

Excited to engage with my esteemed lung cancer colleagues through RealTimeCase, a new platform for sharing expertise and insights in oncology care.